Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emerging markets will be wind in Bayer's sales

This article was originally published in Scrip

Executive Summary

Emerging markets are expected to have helped Bayer increase its 2013 healthcare revenues. These territories now account for around a third of the company's healthcare sales, and have in particular driven growth in the consumer care business. Eastern Europe, Russia and Latin America have been strong recently, whereas China – where Bayer has been one of many multinationals to attract the unwelcome attention of state investigators (scripintelligence.com, 13 September 2013) – has stagnated, after a concerted strategy of growth there helped drive sales up by 23% in 2012.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC024556

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel